Kjell Carlström

No ORCID on file · 16 papers in corpus · active 1980-2005

Study types

  • article 16

Condition tags

  • mesh:D004715 6
  • endometriosis 3
  • die_deep_infiltrating 1
article 2005
Basal release of urokinase plasminogen activator, plasminogen activator inhibitor-1, and soluble plasminogen activator receptor from separated and cultured endometriotic and endometrial stromal and epithelial cells
Fertility and Sterility ·doi:10.1016/j.fertnstert.2004.09.033
article 2004
Increased proteolysis in endometriotic tissue and endometrium in women who develop endometriosis may facilitate invasion
·doi:10.1016/j.ics.2004.06.009
article 2004
Mammographic breast density, hormones, and growth factors during continuous combined hormone therapy
Fertility and Sterility ·doi:10.1016/j.fertnstert.2004.02.096
article 2003
Breast Cell Proliferation in Postmenopausal Women During HRT Evaluated Through Fine Needle Aspiration Cytology
·doi:10.1023/a:1022987618445
article 2002
Effects of hormones on uPA, PAI‐1 and suPAR from cultured endometrial and ovarian endometriotic stromal cells
Acta obstetricia et gynecologica Scandinavica ·doi:10.1034/j.1600-0412.2002.810503.x

PROBLEM: To investigate whether endometriotic stromal cells release the urokinase plasminogen activator, soluble urokinase plasminogen activator receptor and plasminogen activator inhibitor-1. If so, to establish if there are any difference…

article 2002
Effects of hormones on uPA, PAI-1 and suPAR from cultured endometrial and ovarian endometriotic stromal cells1
·doi:10.1080/j.1600-0412.2002.810503.x
article 2001
Interleukin 1β, interleukin-6, and tumor necrosis factor-α in endometriotic tissue and in endometrium
Fertility and Sterility ·doi:10.1016/s0015-0282(00)01752-0
article 1998
Fibrinolytic factors in endometriotic tissue, endometrium, peritoneal fluid, and plasma from women with endometriosis and in endometrium and peritoneal fluid from healthy women
Fertility and Sterility ·doi:10.1016/s0015-0282(98)00285-4
article 1996
Plasma protein changes induced by two orally administered androgen derivatives
·doi:10.3109/00365519609088603

Epostane is a synthetic 17 alpha-alkylated 5 beta-androstane derivative, active following oral administration and devoid of any apparent androgenic, estrogenic or antiestrogenic potency. Circulating concentrations of 13 different plasma pro…

article 1993
Elective ovarian removal and estrogen replacement therapy — effects on sexual life, psychological well-being and androgen status
·doi:10.3109/01674829309084451

Conflicting data have been reported on the psychosexual impact of hysterectomy combined with bilateral oophorectomy. Three age-matched, hysterectomized groups of women were investigated: Group A (n = 33): oophorectomized, not receiving estr…

article 1986
High-Dose Danazol Therapy in Prostatic Cancer Patients: Endocrine and Clinical Effects
·doi:10.1016/s0022-5347(17)45995-7

No AccessJournal of Urology1 May 1986High-Dose Danazol Therapy in Prostatic Cancer Patients: Endocrine and Clinical Effects P.O. Hedlund, D. Freedman, P. Esposti, S. Gershagen, and K. Carlström P.O. HedlundP.O. Hedlund More articles by this…

article 1984
Histochemical localization of specific estrogen and progesterone binding in human endometrium and endometriotic tissue
Acta obstetricia et gynecologica Scandinavica. Supplement ·doi:10.3109/00016348409156973

A histochemical method for the detection of steroid-binding sites in very small tissue specimens was evaluated. Competitive binding experiments proved the method to be sufficiently specific. When applied to endometrium and endometriotic tis…

article 1984
Inhibition of steroid sulfatase activity by danazol
·doi:10.3109/00016348409156994

The hydrolysis of dehydroepiandrosterone sulfate (DHAS) by human liver cells in culture and the hydrolysis of and formation of estradiol-17 beta (E2) from estrone sulfate (E1S) by human breast tumor preparations in vitro were studies in the…

article 1983
Peripheral androgen levels in danazol-treated premenopausal women
Fertility and Sterility ·doi:10.1016/s0015-0282(16)46940-2
article 1981
Effects of prolactin and bromocriptine on the luteal phase in infertile women
·doi:10.1016/0028-2243(81)90033-2
article 1980
Treatment of prostatic carcinoma by gonadotropin inhibition with danazol. A preliminary report.

The effect of an oral gonadotropin agent--Danazol--on 5 patients with prostatic carcinoma was investigated. A phase 2 pilot study, using a combination of repeated clinical findings, hormone analyses and cytological examinations, allowed som…